Home Tags DEXTENZA

Tag: DEXTENZA

Ocular Therapeutix™ (NASDAQ:OCUL) Report Net Revenue Of $5.9 Million In Q3...

Gavins Felicity - 0

Recent Post

Harmony Biosciences (HRMY) : Charting a Course for Sustained Growth

Matt Wade - 0
Harmony Biosciences (NASDAQ: HRMY) recently released its Q2 2024 earnings, demonstrating robust growth and strategic progress. The company reported a 29% year-over-year...

Halozyme’s ENHANZE® (HALO) Technology Empowers OCREVUS ZUNOVO™: A New Era in...

Anebulo Pharmaceuticals Secures NIH Grant for Emergency Cannabis Antidote Development

Applied Therapeutics Surges on Positive FDA Update for Govorestat

Portage Biotech (PRTG): Wild Ride Continues, But Uncertainty Looms

© BioPharma Journal 2020